ASLAN Pharmaceuticals Limited ASLN

$ 0.6 -14.27%

Annual report 2020
added 08-19-2023

ASLAN Pharmaceuticals Limited Income Statement 2011-2024 | ASLN

Annual Income Statement ASLAN Pharmaceuticals Limited

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	85.3 M	65 M	102 M	-	-	-	-	-	-	-
Shares	-	38.4 M	32.5 M	29.9 M	-	-	-	-	-	-	-
Historical Prices	0.955	2.22	2	3.41	-	-	-	-	-	-	-
Net Income	-31.6 M	-16.2 M	-47.1 M	-42.2 M	-40.7 M	-9 M	-13.3 M	-7.36 M	-	-	-
Revenue	-	-	3 M	-	-	11.5 M	-	-	-	-	-
Cost of Revenue	-	-	407 K	-	-	125 K	-	-	-	-	-
Gross Profit	-	-	2.59 M	-	-	11.4 M	-	-	-	-	-
Operating Income	-33.8 M	-16.5 M	-45.6 M	-42.3 M	-39.1 M	-8.7 M	-	-	-	-	-
Interest Expense	443 K	431 K	436 K	441 K	417 K	418 K	-	-	-	-	-
EBITDA	-33.8 M	-16.5 M	-45.6 M	-42.3 M	-39.1 M	-8.58 M	-12.8 M	-7.28 M	-	-	-
Operating Expenses	33.8 M	16.5 M	25.1 M	42.3 M	39.1 M	20 M	-	-	-	-	-
General and Administrative Expenses	11.8 M	7.17 M	8.51 M	10.5 M	9.33 M	6.92 M	6.61 M	2.82 M	-	-	-

All numbers in USD currency

Quarterly Income Statement ASLAN Pharmaceuticals Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency